SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015413
Filing Date
2019-08-13
Accepted
2019-08-13 06:05:34
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_adialpharma.htm 10-Q 356952
2 CERTIFICATION f10q0619ex31-1_adial.htm EX-31.1 9879
3 CERTIFICATION f10q0619ex31-2_adial.htm EX-31.2 10062
4 CERTIFICATION f10q0619ex32-1_adial.htm EX-32.1 3873
5 CERTIFICATION f10q0619ex32-2_adial.htm EX-32.2 3782
6 GRAPHIC image001.jpg GRAPHIC 114303
  Complete submission text file 0001213900-19-015413.txt   3177445

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adil-20190630.xml EX-101.INS 385553
8 XBRL SCHEMA FILE adil-20190630.xsd EX-101.SCH 51561
9 XBRL CALCULATION FILE adil-20190630_cal.xml EX-101.CAL 34977
10 XBRL DEFINITION FILE adil-20190630_def.xml EX-101.DEF 217451
11 XBRL LABEL FILE adil-20190630_lab.xml EX-101.LAB 359945
12 XBRL PRESENTATION FILE adil-20190630_pre.xml EX-101.PRE 290300
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 191018145
SIC: 2834 Pharmaceutical Preparations